DOTHAN, Ala. (WDHN) — With an increase of COVID cases due to the Delta variant, the use of monoclonal antibodies has surged substantially in the state, this has some state medical experts worried about the current supply in the state.
According to Dr. Karen Landers with the Alabama Department of Public Health, the Department of Health and Human Services shifted the monoclonal antibodies ordering process from direct HSS to the state of Alabama. She said the state had to put a process in place and rapidly to get the monoclonal antibodies into the state.
Landers said at this time they are concerned about the state’s supply. She said they are also concerned about being able to give out monoclonal antibodies to those who are eligible.
People who are eligible include those who are at high risk for developing severe COVID and have tested positive but have not yet been admitted to the hospital. Patients must be 12-years of age.
“Put those antibodies in the system while the body itself is trying to fight off this virus,” Dr. Landers said. That people can stay out of the hospital, that really what we are talking about, it really is more important to keep yourself from getting COVID.”
Doctor Landers tells WDHN the best defense against COVID-19 remains being vaccinated. She said even though monoclonal antibodies are effective people shouldn’t rely on this method since not everyone is eligible for the treatment.